SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-007890
Filing Date
2024-03-13
Accepted
2024-03-13 19:52:35
Documents
1
Period of Report
2024-03-11

Document Format Files

Seq Description Document Type Size
1 form4-03132024_110328.html 4  
1 form4-03132024_110328.xml 4 23865
  Complete submission text file 0001415889-24-007890.txt   25302
Mailing Address 890 WINTER STREET SUITE 320 WALTHAM MA 02451
Business Address
Booth Bruce (Reporting) CIK: 0001451612 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 24747523

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)